Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
A 12-week clinical trial showed subjects taking AOD-9604 (1 mg/d) lost an average of 2.6 kg, compared to 0.8 kg in the placebo group.
Such biomarkers could help identify patients most likely to respond to treatment and could facilitate personalized treatment approaches
With professional oversight, patients can receive guidance on proper use, realistic expectations, progress tracking, and any potential concerns along the way
Research shows increased GLUT4 expression leading to better glucose clearance, enhanced insulin receptor sensitivity, and normalized metabolic parameters
What happens if I miss a dose of AOD-9604
US$ 28.13
US$ 20.14
US$ 29.87
US$ 26.72
